Prepare slides for presenting the protocol before the Scientific Advisory Committee for approval
Prepare slides for presenting the protocol before the Scientific Advisory Committee for approval
Created using ChatSlide
This document outlines a request for protocol approval for a four-arm RA efficacy trial, including a counterbalanced n-of-1 sub-trial. It highlights the clinical need due to the global prevalence of RA, particularly among women aged 40-60. Additionally, it discusses the biological rationale, focusing on sclerostin's role in Wnt/β-catenin signalling, T-cell activation costimulation, and the predictive value of MMP-3 for joint destruction.